Floatz logo

Pregabalin

Spinal Cord Injuries

Ju Seok RyuSmall moleculePhase 4 / ApprovedDormant
BBB
75/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
62/ 100
Competitive Position
95/ 100

Competitive context

19 Active assets in the Spinal Cord Injuries cohort.

Asset / SponsorPhaseRating
CYCLOHEXANEACETIC ACID, 1-(AMINOMETHYL)-
MetroHealth Medical Center
Phase 4BB
VENLOR
University of Washington
Phase 4BB
Semaglutide
James J. Peters Veterans Affairs Medical Center
Phase 4BB
Amitriptyline
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Phase 4BB
Brivaracetam
University of Minnesota
Phase 3BB

View all 42 →

Same molecule, other indications

Pregabalin is also rated in:

neuralgiaDormant
A
Indicative ·
82 / 100
View asset →
peripheral neuropathyDormant
A
Indicative ·
82 / 100
View asset →
focal epilepsyDormant
A
Indicative ·
82 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →